Efficacy, Safety, Tolerability of Neramexane in Patients With Subjective Tinnitus

NCT00955799 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

455

Enrollment

INDUSTRY

Sponsor class

Conditions

Subjective Tinnitus

Interventions

DRUG: Neramexane mesylate
DRUG: Placebo

Sponsor

Merz Pharmaceuticals GmbH